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Connexins(Cxs)arecriticalfornormaltissuedevelopment,diﬀerentiation,andcellproliferation.Normalexpressionandfunction
of Cxs are considered to play a role in tumor suppression, but abnormal localization and abnormally increased expression of
Cxs have been found in a variety of carcinomas. Of the Cx family, Cx43 is a most prevalent member and has been known
as a downstream target of β-catenin, a key component of Wnt signaling pathway. We evaluated the expression of Cx43 in
the colonic neoplasia progression sequence with additional attention to the stromal component. Resections of 50 colonic
adenocarcinomas were stained immunohistochemically for Cx43 on paraﬃn embedded sections. Cx43 cytoplasmic expression
increased progressively in the colonic adenocarcinoma sequence in both the epithelial [normal (4 ± 1), adenomatous (20 ± 2),
cancerous (124 ± 10) (P<0.01)], and stromal [normal (19 ± 1), cancerous (45 ± 4) (P<0.01)] components. In the epithelial
component, Cx43 was expressed lower in stage I adenocarcinomas (69 ± 12) compared to stage III/IV (158 ± 10, P<0.01).
Additionally, Cx43 was relatively increased in the adenocarcinoma at the invasive tumor front in all stages. Cx43 may play a critical
roleinthepathogenesisofcoloncancerviagapjunctionorothergapjunctionindependentmechanismssuchastheWnt/β-catenin
pathway.
1.Introduction
Gapjunctionsarespeciﬁccell-to-cellchannelsformedbytwo
hemichannels each of which is composed of six transmem-
brane proteins, called connexin (Cx). Gap junctions permit
directexchangeofsmallmoleculesandsubsequentlybiologic
signaling between cells which are critical for tissue develop-
ment, cellular diﬀerentiation, apoptosis, and cell prolifera-
tion [1, 2]. Of the Cx family, Connexin26 (Cx26), 32 (Cx32),
and 43 (Cx43) are the most widely studied. While Cxs were
initially thought to serve as putative tumor suppressors via
normal functioning gap junctions [3–6], more recent studies
have found aberrant increased expression of Cxs in a variety
ofcarcinomasandsarcomas[7–9].Inaddition,Cxshavealso
been observed to have transcriptional function independent
of their gap junction function (36, 37). Because cell contact-
mediatedsignalingisimportantincarcinogenesisbyregulat-
ing invasion and metastasis [10–12], we hypothesize that Cxs
may also serve a role in these processes through gap junc-
tion dependent or independent mechanisms. Additionally,
because epithelial stromal interactions and signaling are also
critical for normal cell biology and cancer cell migration, we
hypothesized that the expression of Cxs may be altered in the
mesenchymal tissue in neoplastic progression.
Colon cancer is one of the most common cancers in
the Western countries and serves as an ideal model sys-
tem to study neoplastic progression. Speciﬁcally, resection
specimens usually contain normal colon, the adenomatous
precursor lesion, variably invasive cancer, and, depending
on stage, metastatic disease. Cx43, an important member of2 Gastroenterology Research and Practice
the Cx family, has been shown to be present in the normal
human epithelium of the colon [13, 14]. However, the role
of Cx43 in the physiology of the colon is currently poorly
understood. Aberrant Cx43 expression has been found in
several types of tumor, including liver, prostate, breast,
and lung [12, 15–21]. Importantly, GJA1/Cx43 has been
reported to be frequently mutated in tumors of the colon,
suggesting that inactivation of Cx43 can be involved in
colorectal carcinogenesis [14]. However, the role of Cx43 in
carcinogenesis remains to be elucidated.
Adenomatouspolyposiscoli(APC)playsimportantroles
in a wide range of cellular functions such as proliferation,
migration, diﬀerentiation, and apoptosis in colonocytes [22–
25].APCisimportantinWntsignalling,whereitparticipates
together with axin and glycogen synthase kinase 3b (GSK3b)
to target the adhesion molecule and transcription factor β-
catenin for degradation. APC mutations have been found
in 40–80% of sporadic colon cancer and in almost all cases
of familial adenomatous polyposis [26–28]. The truncated
APC gene product causes dysregulation of β-catenin. When
van der Heyden et al. [29] investigated the eﬀects of Wnt1
overexpression on gap junctional communication in PC12
cells, they reported that Wnt1 expressing clones displayed
anincreasedelectricalandchemicalcoupling.Thiscoincided
withanincreasedexpressionofCx43mRNA.Also,induction
of Wnt1 expression in a mammary epithelial cell line leads to
an increase in gap junctional communication and Cx43 pro-
tein expression. In the absence of functional APC, β-catenin
accumulatesinthenucleuswhereitcanturnontranscription
of several genes, including the gap junction protein Cx43,
COX-2, cyclin-D1, and PPARδ [29–33]. Therefore, Cx43
could be a potential biomarker for colorectal carcinoma.
To the best of our knowledge, the importance of
connexin43 in colorectal carcinogenesis has not been well
investigated. Little is known about the expression of Cx43
in colorectal carcinoma; especially in clinically and patho-
logically well-characterized cases, the goal of our study
was to evaluate the expression of Cx43 in a series of well
characterized colorectal adenocarcinomas. Speciﬁcally, we
studied (1) the expression and localization of Cx43 in colon
cancerprogression sequence with attention to both epithelial
and stromal compartments and (2) correlation of Cx43
expression in colon cancer with its pathologic stage and
histologic grade.
2.MaterialsandMethods
This retrospective study was performed in 50 cases of
primary resections of colonic adenocarcinoma between the
years 2000 to 2005 from the Hospital of the University of
Pennsylvania. It was approved by the Institutional Review
Boards (IRB). Cases with macroscopic or microscopic
residue of tumor cells at the surgical margins and those with
preoperative chemo- or irradiation therapy were excluded.
All cases were histopathologically diagnosed according to the
American Joint Committee on Cancer (AJCC) classiﬁcation
and TNM staging. Lymph node metastases were checked by
histopathological examination in all cases. Distant metas-
tases were diagnosed by histopathological examination. A
representative block was selected in each case for the study.
Normal colonic mucosa was present in the selected block in
37 cases and adenoma in 14 cases.
2.1. Immunohistochemistry. Tissue specimens were ﬁxed in
10% formalin and embedded in paraﬃn in all cases. Sections
(5μm) were deparaﬃnized with Xylene 3 times for 3–5 min-
utes each. Antigen retrieval was performed in 10mmoL/L of
sodium citrate (pH 7.6) in a microwave for 4 minutes twice
at 70% power level. Endogenous peroxidase was inactivated
by incubation in 5% hydrogen peroxide for 5 minutes.
Nonspeciﬁc binding sites were blocked by incubating with
2% normal horse serum for 20 minutes. Connexin43
immunohistochemical stains were performed with a poly-
clonal goat connexin43 antibody (clone CXN-6, Santa Cruz
Biotechnology) with 1:200 dilution and incubation at room
temperature for 60 minutes. Immunoreactivity was visual-
ized by using EnVision+ system—HRP labeled polymer on a
DAKO autostainer (DAKO, Carpinteria, CA).
Double Cx43 and Beta-Catenin Staining. Cx43 stain was
performed as above said. Afterwards the beta-catenin stain
was performed manually. After boiled in 1× citrate buﬀer
for 20 minutes, sections were incubated with mouse anti-
beta-catenin antibody (monoclonal, BD Bioscience cat no.
610154) at 1:250 dilution for 30 minutes at room tem-
perature followed by alkaline phosphatase-conjugated goat
antimouse antibody (DAKO, Carpinteria, CA) at 1:75 dilu-
tion for 30 minutes and then exposed to Perma Red (Dako,
Carpinteria, CA) for 5 minutes at RT and counterstained
with hematoxylin.
2.2. Evaluation of Cx43 Immunostaining. Cx43 immunos-
taining was evaluated by three authors independently,
blinded to patient outcome and all clinicopathologic ﬁnd-
ings. The immunohistochemical staining was analyzed and
classiﬁed into four groups based on the staining intensity (0,
absent; 1+, weak; 2+, intermediate; 3+, strong staining). The
percentage (%) and staining intensity (0–3) of epithelial and
stromal cells in normal, adenomatous, and cancerous areas
were determined. The total staining score was calculated by
the sum of staining intensity multiplied by its percentage
yielding a possible score of 0–300. In the case of hetero-
geneous staining within the same sample, we determined
the percentage of diﬀerent staining intensities individually in
each area and calculated the total sum.
2.3. Statistical Analysis. Statistical analysis was done using
the Stata software (StataCorp, College Station, TX). The as-
sociationofstainingintensitywithclinicopathologicpatterns
was assessed with unpaired Student t-test, when appropriate.
All data were expressed as the mean ± SR. P values of < 0.05
were accepted as statistically signiﬁcant.
3. Results
3.1. Clinicopathological Characteristics of Patients with Colon
Cancer. The average age of the patients was 61 years (range,Gastroenterology Research and Practice 3
Table 1: Clinicopathological characteristics of patients with colon cancer.
Parameters Stage I (N = 19) Stag III/IV (N = 31) P
Median age 60.0 ±14.06 1 .5 ±10.5 >0.05
Male:female ratio 8:11 18:13 >0.05
Histologic grade
WD 2 0
MD 15 21
PD 2 10 >0.05
WD: Well diﬀerentiated, MD: Moderately diﬀerentiated, PD: Poorly diﬀerentiate.
1+
(a)
2+
(b)
3+
(c)
Figure 1: The expression of Cx43 in colonic adenocarcinoma was evaluated according to the intensity of the staining as follows: 1, very weak
expression (1+); 2, moderate expression (2+); 3, strong expression (3+) (Original magniﬁcation ×200).
Normal mucosa
(a)
Tubular adenoma
(b)
Severe dysplasia
(c)
Figure 2: The expression of Cx43 in normal colonic mucosa, tubular adenoma, and severe dysplasia (Original magniﬁcation ×200). There
is an increase in cytoplasmic Cx43 expression from normal epithelium (Cx43 score 4 ± 1) to tubular adenoma/severe dysplasia (Cx43 score
20 ±2).
35–82; SD, 14.28 years). Of 50 patients, 19 (38%) were
diagnosed as AJCC TNM stage I, 22 (44%) were diagnosed
as stage III, and 9 (18%) were diagnosed as stage IV. Histo-
logical grades of the tumor are low in 2 (4%), moderate in 36
(72%), and high in 12 (24%) cases. There is no significant
diﬀerence in age and sex between stage I and stage III/IV
(Table 1). Although more cases with poorly diﬀerentiated
adenocarcinoma in stage III/IV are seen, there is no his-
tologic grade diﬀerence between stage I and stage III/IV
(Table 1).
3.2. Expression of Cx43 in the Neoplastic Epithelium (Colon
Cancer Progression Pathway). Figure 1 depicts the diﬀer-
ent Cx43 staining intensity in colorectal adenocarcinoma.
Although Cx43 protein was reported to express in normal
colonic mucosa [14], we only rarely observed punctuate in-
tercellular staining of Cx43 in normal colonic mucosa. In
contrast, we found a progressive increase in cytoplasmic
Cx43 expression from normal epithelium to tubular adeno-
ma/severe dysplasia (Figure 2) and to carcinoma (Figure 3).
Cx43 score according to each histologic category was re-
corded as 4 ± 1i nn o r m a l( n = 37), 20 ± 2i na d e n o m a
(n = 14), and 124 ± 10 in cancer (n = 50) (P<0.01).
VariableCx43expressionwasdetectedincoloncancertissues
in all cases (50/50). Cx43 was expressed predominantly
in the cytoplasm in colon cancer and precancer epithelia,
althoughamixed(cytoplasmicandmembranous)stainingin
stage III/IV colonic carcinoma was seen. Additionally, Cx434 Gastroenterology Research and Practice
Stage I
(a)
Stage III/IV
(b)
Figure 3: The diﬀerence in Cx43 expression in stage I and stage III/IV colonic adenocarcinoma (original magniﬁcation ×200). A higher
level of Cx43 expression was signiﬁcantly associated with AJCC stage III/IV adenocarcinomas (Cx43 score 158 ± 1 0 ) ,a sc o m p a r e dt oA J C C
stage I (Cx43 score 69 ±12).
1+
(a)
2+
(b)
3+
(c)
Figure 4:TheexpressionofCx43incolonicstromawasevaluatedaccordingtotheintensityofthestainingasfollows:1,veryweakexpression
(1+); 2, moderate expression (2+); 3, strong expression (3+) (original magniﬁcation ×200).
reactivity was relatively increased in the invasive front of
the adenocarcinoma in all cases of diﬀerent stages (data not
shown).
3.3. Expression of Cx43 in Stromal Component. Cx43 expres-
sion was also localized to connective tissue and muscular
tissue in the samples, primarily in the connective tissue in
close proximity to epithelial cells (Figure 4). Cx43 reactivity
was stronger in the stromal components adjacent to cancer-
ous epithelium than benign epithelium: normal (Cx43 score
19 ± 1), cancer (Cx43 score 45 ± 4) (P<0.01) (Figure 6).
However, there is no signiﬁcant stage diﬀerence (Stage I:
42 ±4, Stage III/IV: 46 ± 6) (P>0.05).
3.4.ExpressionofCx43inColonicAdenocarcinomainRelation
to Stage and Grade. A higher level of Cx43 expression was
signiﬁcantly associated with AJCC stage III/IV adenocarci-
nomas (158 ± 10), (P<0.01) as compared to AJCC stage
I( 6 9± 12) (Figure 3). Cx43 expression did not show any
correlation with histologic grade.
3.5. Coexpression of Cx43 and Beta-Catenin. After evaluation
of the initial Cx43 staining, 12 cases, 6 with low Cx43
reactivity and 6 with high Cx43 reactivity, were selected for
double staining. Nuclear and sometimes cytoplasmic beta-
catenin reactivity (red) was observed in neoplastic cells.
However, for practical reason, only nuclear reactivity was
analyzed against the Cx43 cytoplasmic reactivity (brown)
on double staining. No nuclear beta-catenin reactivity was
detected in nonneoplastic colonic epithelium. Coexpression
of Cx43 and beta-catenin was commonly seen but is not
exclusive as other tumor cells in the same tumor frequently
exhibited only either Cx43 or beta-catenin. There was no
correlation in the level of immunoreactivity between Cx43
and beta-catenin (data not shown). No nuclear beta-catenin
reactivity was detected in any stromal cells regardless of their
Cx43 reactivity (Figure 5).
4. Discussion
It was suggested that loss of gap junction protein expression,
aberrant cytoplasmic localization, and disturbance of gapGastroenterology Research and Practice 5
(a) (b) (c)
(d) (e)
Figure 5:TherelationshipbetweenCx43expressionandnuclearbeta-cateninexpressionincolonicadenocarcinoma(originalmagniﬁcation
×200). (a) Coexpression of Cx43 (brown cytoplasmic staining) and nuclear beta-catenin (red nuclear staining). Note. Peritumoral stromal
cells exhibited only Cx43 but not beta-catenin reactivity. (b) Tumoral tissue exhibited heterogeneous expression of Cx43 and nuclear beta-
catenin. (c) Tumoral tissue with expression of Cx43 only. (d) Tumoral tissue with expression of beta-catenin only. (e) Tumoral tissue with
no expression of Cx43 or beta-catenin.
Normal mucosa
(a)
Colon carcinoma
(b)
Figure 6: The diﬀerence in Cx43 expression in the stromal component in normal mucosa and colonic adenocarcinoma (original
magniﬁcation ×200). Cx43 reactivity was stronger in the stromal components adjacent to cancerous epithelium than benign epithelium:
normal (Cx43 score 19 ±1), cancer (Cx43 score 45 ±4).
junction intercellular communication would be important
events in carcinogenesis, invasion, and metastasis [12, 34].
There has been a large body of literature to suggest that
gap junctions are implicated in cellular growth control and
tissue diﬀerentiation, and normal membranous expression
of Cxs has tumor suppressive eﬀe c tt h a tc o n t r o l st u m o r
progression by regulating cell growth and diﬀerentiation.
However, the role of Cxs in carcinogenesis and metastasis
remains controversial, because it is still unclear whether Cx
expression is required for invasion and metastasizing [35].
In our study, the intercellular/membranous staining was
rareandonlysporadicallyseeninnormalcolonicepithelium,
but cytoplasmic expression of Cx43 was frequently observed
in colonic cancer cells. In addition, we found that the level
of Cx43 expression was signiﬁcantly associated with higher
AJCCstageIII/IVbutdidnothaveimpactonthehistological6 Gastroenterology Research and Practice
grading. We speculate that cytoplasmic expression of Cx43
might reﬂecttranscriptional or posttranscriptional defectsof
this protein during colorectal carcinogenesis, or a product
of the mutated gene, a common event in colorectal cancer
[14]. If connexins do not assemble to form functional gap
junction channels such as in the case of aberrant cytoplasmic
accumulation and expression, they might cause alteration
in expression of diﬀerent genes in cooperation with other
proteins [36, 37], or they may function as adhesion pro-
teins to form adhesive plaques that could severely impair
signaling pathways [38]. It has been demonstrated that
loss of intercellular communication correlates with high
metastatic potential of mammary adenocarcinoma cells [18]
and that connexins may be involved in intravasation and
extravasation of lung cancerous cells [12]. It has been
speculated that connexins may play an important role in
the extravasation of cancerous cells into lymphoid tissue
by formation of gap junctions between tumor cells and
endothelial cells in lymph node vessels [18]. Increased
expression of Cx43 has been reported in lymph node
metastasescomparedtoprimarytumortosuggestapotential
role of Cx43 in metastatic process [18, 39]. Dubina et al.
[14] reported that the mutational alterations in the carboxyl-
terminal region of Cx43 are involved in advanced stages of
progression of human colon cancer. The carboxyl-terminal
tail of Cx43 contains several motifs for phosphorylation by
diﬀerent protein kinases, which is essential for traﬃcking,
gap junction assembly, channel gating, and turnover of
Cx43. The frameshift mutations in colon tumors appear
to abolish particularly eﬀectively most if not all functional
properties of this part of the protein and thus could have
a strong impact on cell growth, morphology, and motility
that would be critical for cancer progression. However, the
fact that Cx43 mutations have been found only in invasive
structures of exophytic colon adenocarcinoma, but neither
among their benign precursors adenomatous polyps nor
in endophytic carcinomas, suggests that Cx43 mutational
alterations are limited to this speciﬁc growth type of human
colon neoplasms and are involved at a fairly late stage
of their progression [14]. Nevertheless, more and more
evidences have merged to suggest that the loss of normal
function of connexins during carcinogenesis is not only
d u et og e n em u t a t i o n s ,b u t ,m o r ei m p o r t a n t l y ,a l s od u e
to the multiple steps of possible alteration in connexin
expression, including lack of transcription of connexin
genes, lack of translation of connexin mRNA, and lack of
membrane targeting leading to accumulation of connexin
proteins in the cytoplasm. As Cx43 is a target for β-
catenin/Tcf-mediated transcription [29], accumulated β-
catenin in colon cancer may increase Cx43 expression in
colonic mucosal epithelium. This hypothesis was supported
by the ﬁnding in cardiomyocytes in which β-catenin was
shown to interact directly with Cx43 and to transactivate
Cx43 [40]. Our study of double staining revealed that
colorectal adenocarcinomas commonly expressed both beta-
catenin and Cx43 in the same or diﬀerent cells but failed to
demonstrate correlation of expression of these two factors in
situ. However, these results were not completely unexpected
given the fact that beta-catenin immunoreactivity has not
been consistently shown to correlate with various pathologic
and clinical parameters of colorectal cancer in literatures
[41, 42]. The role of beta-catenin in regulating Cx43 in
colorectal cancer is likely more complex than expected and
needs to be further evaluated. The lack of any nuclear beta-
catenin reactivity seen in the Cx43 positive peritumoral
stromal cells also suggested other pathways involved in Cx43
expression in colorectal cancer. In any case, our ﬁndings
of higher Cx43 expression in neoplastic epithelium and
advanced stage of colorectal cancer are consistent with these
previous observations on the role of Cx43 in clinically well-
characterized cases and suggest an oncogenic role of Cx43
which might be gap junction dependent or independent.
Cx43 expression was also located to connective tissue
and muscular tissue in benign bowel and colon cancer. We
observed that Cx43 was relatively elevated in the connective
tissue in close proximity to epithelial cells, and higher
Cx43 reactivity was in the stromal components adjacent to
cancer than to benign epithelium. It is thought that the
role of gap junctions in epithelial-stromal interactions may
be important in carcinogenesis. Husøy et al. [30]f o u n da n
increased expression of Cx43 in the stroma around intestinal
tumors in animal (mice) with the multiple intestinal neo-
plasia (Min). Furthermore, the increased Cx43 expression in
stromal myoﬁbroblasts was colocalized with COX-2, which
expression is well known to be increased in both humans
and mice adenomas. Myoﬁbroblasts are suggested to secrete
signaling molecules that could stimulate invasion of cancer
cells, since primary cultures of subepithelial myoﬁbroblasts
from human colon promote the migration of epithelial cells
[43]. Similar to adenomas in Min mouse intestine, Cx43 has
also been reported to be increased in stromal cells of human
breast carcinomas. Therefore, it is conceivable that peritu-
moral stromal Cx43 expression observed in our study might
reﬂect a similar biologic function of Cx43 in colonic carcino-
genesis as observed in the animal and experimental models.
The signiﬁcance of increased peritumoral stromal Cx43
expression in carcinogenesis needs to be further investigated
for its role in epithelial-mesenchymal transition/interaction.
In conclusion, in this study, we have found that the level
of Cx43 expression progressively increased along the colonic
carcinoma progression sequence and advanced tumor stage
in the neoplastic epithelium and the stroma surrounding
cancerous epithelium. The ﬁndings suggest that connexin43
may play a critical role in the pathogenesis of colon cancer
likely via multifactorial mechanisms including, but not lim-
ited to, abnormal gap junction formation, transcriptional
activity of cytoplasmic Cx43, and abnormal epithelial-stro-
mal interactions. Study is needed to further understand the
molecular basis of Cx43 oncologic eﬀect in colon cancer
and how Cx43 is regulated in colonic carcinoma progression
sequence. Immunohistochemical evaluation of Cx43 expres-
sion might have prognostic signiﬁcance as there is a corre-
lation of signiﬁcantly higher level of Cx43 expression with
more advanced stage colon carcinomas. However, evaluation
of Cx43 in larger cohort of cases with clinical outcome data
is needed to further assess this potential prognostic role of
Cx43 in colorectal cancer.Gastroenterology Research and Practice 7
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